LA
TMO icon

Layline Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Layline Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
+640
New +$307K 0.29% 48

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Layline Advisors's TMO Position: Q2 2026 in Review

Layline Advisors opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 640 shares worth $321K. The stake represents 0.29% of the portfolio and ranks #48 among its holdings.

2,608 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Layline Advisors held 640 shares of Thermo Fisher Scientific worth $321K as of Q2 2026.
  • Thermo Fisher Scientific was a new Layline Advisors position in Q2 2026.
  • Thermo Fisher Scientific made up 0.29% of Layline Advisors's portfolio in Q2 2026, its #48 holding.
  • 2,608 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Layline Advisors's 13F filing for Q2 2026, filed 20 Aug 2026.